Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers

Anantharaman, 2002, Comparative genomics and evolution of proteins involved in RNA metabolism, Nucleic Acids Res., 30, 1427, 10.1093/nar/30.7.1427 Avdulov, 2004, Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells, Cancer Cell, 5, 553, 10.1016/j.ccr.2004.05.024 Baltz, 2012, The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts, Mol. Cell, 46, 674, 10.1016/j.molcel.2012.05.021 Beroukhim, 2010, The landscape of somatic copy-number alteration across human cancers, Nature, 463, 899, 10.1038/nature08822 Brooke, 2011, FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth, Cancer Res., 71, 914, 10.1158/0008-5472.CAN-10-0874 Burd, 1994, Conserved structures and diversity of functions of RNA-binding proteins, Science, 265, 615, 10.1126/science.8036511 Castello, 2012, Insights into RNA biology from an atlas of mammalian mRNA-binding proteins, Cell, 149, 1393, 10.1016/j.cell.2012.04.031 Castello, 2013, RNA-binding proteins in Mendelian disease, Trends Genet., 29, 318, 10.1016/j.tig.2013.01.004 Correa, 2016, Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma, Genome Biol., 17, 125, 10.1186/s13059-016-0990-4 Cowley, 2014, Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies, Sci. Data, 1, 140035, 10.1038/sdata.2014.35 Dees, 2012, MuSiC: identifying mutational significance in cancer genomes, Genome Res., 22, 1589, 10.1101/gr.134635.111 Derynck, 2003, Smad-dependent and Smad-independent pathways in TGF-beta family signalling, Nature, 425, 577, 10.1038/nature02006 Ding, 2008, Somatic mutations affect key pathways in lung adenocarcinoma, Nature, 455, 1069, 10.1038/nature07423 Foulkes, 2014, DICER1: mutations, microRNAs and mechanisms, Nat. Rev. Cancer, 14, 662, 10.1038/nrc3802 Fu, 2014, Context-dependent control of alternative splicing by RNA-binding proteins, Nat. Rev. Genet., 15, 689, 10.1038/nrg3778 Futreal, 2004, A census of human cancer genes, Nat. Rev. Cancer, 4, 177, 10.1038/nrc1299 Gerstberger, 2014, A census of human RNA-binding proteins, Nat. Rev. Genet., 15, 829, 10.1038/nrg3813 Glisovic, 2008, RNA-binding proteins and post-transcriptional gene regulation, FEBS Lett., 582, 1977, 10.1016/j.febslet.2008.03.004 Graff, 2007, Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity, J. Clin. Invest., 117, 2638, 10.1172/JCI32044 Haag, 2015, NSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs, RNA, 21, 1532, 10.1261/rna.051524.115 Hamimes, 2005, RDM1, a novel RNA recognition motif (RRM)-containing protein involved in the cell response to cisplatin in vertebrates, J. Biol. Chem., 280, 9225, 10.1074/jbc.M412874200 Huether, 2014, The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes, Nat. Commun., 5, 3630, 10.1038/ncomms4630 Jankowsky, 2015, Specificity and nonspecificity in RNA-protein interactions, Nat. Rev. Mol. Cell Biol., 16, 533, 10.1038/nrm4032 Kandoth, 2013, Mutational landscape and significance across 12 major cancer types, Nature, 502, 333, 10.1038/nature12634 Karni, 2007, The gene encoding the splicing factor SF2/ASF is a proto-oncogene, Nat. Struct. Mol. Biol., 14, 185, 10.1038/nsmb1209 Kechavarzi, 2014, Dissecting the expression landscape of RNA-binding proteins in human cancers, Genome Biol., 15, R14, 10.1186/gb-2014-15-1-r14 Lagadec, 2014, The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells, Stem Cells, 32, 135, 10.1002/stem.1537 Law, 2014, voom: Precision weights unlock linear model analysis tools for RNA-seq read counts, Genome Biol., 15, R29, 10.1186/gb-2014-15-2-r29 Lawrence, 2013, Mutational heterogeneity in cancer and the search for new cancer-associated genes, Nature, 499, 214, 10.1038/nature12213 Lawrence, 2014, Discovery and saturation analysis of cancer genes across 21 tumour types, Nature, 505, 495, 10.1038/nature12912 Lazaris-Karatzas, 1990, Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap, Nature, 345, 544, 10.1038/345544a0 Lee, 2006, Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway, Hum. Mol. Genet., 15, 201, 10.1093/hmg/ddi430 Lee, 2014, Upregulation of eIF5B controls cell-cycle arrest and specific developmental stages, Proc. Natl. Acad. Sci. USA, 111, E4315, 10.1073/pnas.1320477111 Liu, 2017, Structural basis for substrate binding and catalytic mechanism of a human RNA:m5C methyltransferase NSun6, Nucleic Acids Res., 45, 6684, 10.1093/nar/gkx473 Long, 2016, Sequence-specific and Shape-selective RNA Recognition by the Human RNA 5-Methylcytosine Methyltransferase NSun6, J. Biol. Chem., 291, 24293, 10.1074/jbc.M116.742569 Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702 Lukong, 2008, RNA-binding proteins in human genetic disease, Trends Genet., 24, 416, 10.1016/j.tig.2008.05.004 Lunde, 2007, RNA-binding proteins: modular design for efficient function, Nat. Rev. Mol. Cell Biol., 8, 479, 10.1038/nrm2178 Martin, 2009, mRNA localization: gene expression in the spatial dimension, Cell, 136, 719, 10.1016/j.cell.2009.01.044 Melloni, 2014, DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes, Genome Med., 6, 44, 10.1186/gm563 Mermel, 2011, GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers, Genome Biol., 12, R41, 10.1186/gb-2011-12-4-r41 Mitchell, 2014, Principles and properties of eukaryotic mRNPs, Mol. Cell, 54, 547, 10.1016/j.molcel.2014.04.033 Mittal, 2009, Dissecting the expression dynamics of RNA-binding proteins in posttranscriptional regulatory networks, Proc. Natl. Acad. Sci. USA, 106, 20300, 10.1073/pnas.0906940106 Miyoshi, 2007, Bystin in human cancer cells: intracellular localization and function in ribosome biogenesis, Biochem. J., 404, 373, 10.1042/BJ20061597 Moore, 2005, From birth to death: the complex lives of eukaryotic mRNAs, Science, 309, 1514, 10.1126/science.1111443 Moore, 2009, Pre-mRNA processing reaches back to transcription and ahead to translation, Cell, 136, 688, 10.1016/j.cell.2009.02.001 Musunuru, 2003, Cell-specific RNA-binding proteins in human disease, Trends Cardiovasc. Med., 13, 188, 10.1016/S1050-1738(03)00075-6 Paz, 2007, Altered adenosine-to-inosine RNA editing in human cancer, Genome Res., 17, 1586, 10.1101/gr.6493107 Pleasance, 2010, A comprehensive catalogue of somatic mutations from a human cancer genome, Nature, 463, 191, 10.1038/nature08658 Preitner, 2014, APC is an RNA-binding protein, and its interactome provides a link to neural development and microtubule assembly, Cell, 158, 368, 10.1016/j.cell.2014.05.042 Quinlan, 2010, BEDTools: a flexible suite of utilities for comparing genomic features, Bioinformatics, 26, 841, 10.1093/bioinformatics/btq033 Rahman, 2015, Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results, Bioinformatics, 31, 3666, 10.1093/bioinformatics/btv377 Santarius, 2010, A census of amplified and overexpressed human cancer genes, Nat. Rev. Cancer, 10, 59, 10.1038/nrc2771 Schaeffer, 2010, Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival, BMC Cancer, 10, 59, 10.1186/1471-2407-10-59 Sebestyén, 2016, Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks, Genome Res., 26, 732, 10.1101/gr.199935.115 Singh, 2005, Building specificity with nonspecific RNA-binding proteins, Nat. Struct. Mol. Biol., 12, 645, 10.1038/nsmb961 Sonenberg, 2009, Regulation of translation initiation in eukaryotes: mechanisms and biological targets, Cell, 136, 731, 10.1016/j.cell.2009.01.042 Stratton, 2009, The cancer genome, Nature, 458, 719, 10.1038/nature07943 Suzuki, 1998, A cytoplasmic protein, bystin, interacts with trophinin, tastin, and cytokeratin and may be involved in trophinin-mediated cell adhesion between trophoblast and endometrial epithelial cells, Proc. Natl. Acad. Sci. USA, 95, 5027, 10.1073/pnas.95.9.5027 Vinagre, 2013, Frequency of TERT promoter mutations in human cancers, Nat. Commun., 4, 2185, 10.1038/ncomms3185 Vogelstein, 2013, Cancer genome landscapes, Science, 339, 1546, 10.1126/science.1235122 Wang, 2009, Bystin-like protein is upregulated in hepatocellular carcinoma and required for nucleologenesis in cancer cell proliferation, Cell Res., 19, 1150, 10.1038/cr.2009.99 Weinstein, 2013, The Cancer Genome Atlas Pan-Cancer analysis project, Nat. Genet., 45, 1113, 10.1038/ng.2764 Zack, 2013, Pan-cancer patterns of somatic copy number alteration, Nat. Genet., 45, 1134, 10.1038/ng.2760 Zong, 2014, The RNA-binding protein QKI suppresses cancer-associated aberrant splicing, PLoS Genet., 10, e1004289, 10.1371/journal.pgen.1004289